![Chrystal Louis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chrystal Louis
Technik-/Wissenschafts-/F&E-Leiter bei
TSCAN THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Chrystal U.
Louis is currently Chief Medical Officer at TScan Therapeutics, Inc. since 2024.
Formerly, Dr. Louis was Senior VP-Hematology Clinical Development at Zentalis Pharmaceuticals, Inc. from 2022 to 2024, Vice President & Head-Medical Affairs at CRISPR Therapeutics, Inc. from 2020 to 2022, and Executive Director-Myeloid Diseases at Celgene Corp.
from 2018 to 2019.
Education includes graduate and doctorate degrees from Tulane University School of Medicine and an undergraduate degree from Southwestern University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Chrystal Louis
| Unternehmen | Position | Beginn |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.04.2024 |
Ehemalige bekannte Positionen von Chrystal Louis
| Unternehmen | Position | Ende |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2024 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Corporate Officer/Principal | 01.11.2022 |
| CELGENE | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Chrystal Louis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Southwestern University
 Southwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
